Caldwell Sutter Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $250K | Buy |
5,405
+168
| +3% | +$7.78K | 0.11% | 172 |
|
|
2025
Q1 | $319K | Buy |
5,237
+88
| +2% | +$5.37K | 0.15% | 151 |
|
|
2024
Q4 | $291K | Buy |
5,149
+177
| +4% | +$10K | 0.14% | 160 |
|
|
2024
Q3 | $257K | Sell |
4,972
-1,509
| -23% | -$78.1K | 0.12% | 170 |
|
|
2024
Q2 | $269K | Sell |
6,481
-423
| -6% | -$17.6K | 0.13% | 159 |
|
|
2024
Q1 | $374K | Buy |
6,904
+1,311
| +23% | +$71.1K | 0.18% | 132 |
|
|
2023
Q4 | $287K | Sell |
5,593
-1,577
| -22% | -$80.9K | 0.15% | 147 |
|
|
2023
Q3 | $416K | Buy |
7,170
+1,220
| +21% | +$70.8K | 0.23% | 110 |
|
|
2023
Q2 | $381K | Buy |
5,950
+2,993
| +101% | +$191K | 0.2% | 119 |
|
|
2023
Q1 | $205K | Buy |
2,957
+1,532
| +108% | +$106K | 0.15% | 120 |
|
|
2022
Q4 | $103K | Buy |
+1,425
| New | +$103K | 0.09% | 140 |
|